Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Virus or component thereof
Patent
1997-06-04
1999-11-30
Eisenschenk, Chris
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Virus or component thereof
424 936, 424816, 4352351, 435236, 435237, 435239, A61K 3576, A61K 3912
Patent
active
059938226
ABSTRACT:
The present invention provides a vaccine which is protective against avian polyomavirus infection in a bird which is classified as being a member of the Psittaciformes order which comprises an immunogenic amount of a modified live avian polyomavirus in a pharmaceutically acceptable carrier. Methods are also provided for preventing avian polyomavirus infection in a bird, or in several different species of birds, classified as being a member of the Psittaciformes order, comprising administering a vaccine comprising an immunogenic amount of a modified live avian polyomavirus and a pharmaceutically acceptable carrier. A preferred embodiment provides a modified live avian polyomavirus vaccine for prevention of wild-type infection in a Budgerigar, lovebird or Cockatiel.
REFERENCES:
patent: 5523088 (1996-06-01), Ritchie et al.
patent: 5747045 (1998-05-01), Ritchie et al.
Ritchie et al., "Polyomavirus Infections in Adult Psittacine Birds" J. Assoc. Avian Vet. 5:202-206 (1991).
Graham and Calnek, "Papovavirus Infection in Hand-Fed Parrots: Virus Isolation and Pathology" Avian Diseases31:398-410 (1985).
Ritchie et al., "Avian Polyomavirus: An Overview" J. Assoc. Avian Vet.5:12-14 (1991).
Stoll et al., "Molecular and biological characteristics of avian polyomaviruses: isolates from different species of birds indicate that avian polyomaviruses form a distinct subgenus within the polyomavirus genus" J. Gen. Virology74:229-237 (1993).
Gaskin, J. M., "Adverse Reactions to Currnet Pet Bird Vaccine" J. Assoc. Avian Vet.5:12-14 (1991).
Ritchie et al., "Efficacy of an Inactivated Avian Polyomavirus Vaccine" J. Assoc. Avian Vet.7:187-192 (1993).
Niagro et al., "Avian Polyomavirus: Discordance Between Neutralizing Antibody Titers and Viral Shedding in an Aviary" Proceedings Association of Avian Veterinarians 22-26 (1991).
Epstein et al., "Not all potentially neutralizing vaccine-induced antibodies to Epstein-Barr virus ensure protection of susceptible experimental animals" Clin. Exp. Immunol. 63:485-490 (1986).
Della-Porta et al., "An Experimental Inactivated Virus Vaccine Against Bovine Ephemeral Fever. 2. Do Neutralizing Antibodies Protect Against Infection?" Veterinary Microbiology4:197-208 (1979).
Dykstra et al., "Investigations of budgerigar fledgling disease virus" Am. J. Vet. Res. 45(9):1883-1887 (1984).
Ritchie et al., "Susceptibility of Avian Polyomavirus to Inactivation" Journal of the Association of Avian Veternarians7(4):193-195, 1993.
Ritchie et al., "Antibody Response and Local Reactions to Adjuvanted Avian Polyomavirus Vaccines in Psittacine Birds",Journal of the Association of Avian Veterinarians vol. 8, No. 1 pp. 21-26 (1994).
Lehn and Mueller, "Cloning and Characterization of Budgerigar Fledgling Disease Virus, an Avian Polyomavirus",Virology, 151, 362-370 (1986).
Wainwright, et al., "Serological Evaluation of Some Psittachformes for Budgerigar Fledgling Disease Virus", Avian Diseases,31:673-676, 1987.
Stoll et al. 1994 Journal of General Virology 75 (9) 2261-2269, Sep. 1994.
Lukert Phil D.
Pesti Denise
Ritchie Branson W.
Eisenschenk Chris
University of Georgia Research Foundation Inc.
Zeman Mary K.
LandOfFree
Modified live avian polymavirus vaccine in psittacine birds does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Modified live avian polymavirus vaccine in psittacine birds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Modified live avian polymavirus vaccine in psittacine birds will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1668175